Trial Profile
A Phase I Dosimetry, Biodistribution and Safety Study of BMS747158 in Healthy Subjects Undergoing 2-Day Rest/Stress Positron Emission Tomography
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Nov 2020
Price :
$35
*
At a glance
- Drugs Flurpiridaz F 18 (Primary)
- Indications Coronary artery disease
- Focus Diagnostic use
- Sponsors Lantheus Medical Imaging
- 28 Aug 2014 New trial record